Teladoc (NYSE:TDOC) updated its FY18 earnings guidance on Tuesday. The company provided earnings per share (EPS) guidance of -$1.36 to -$1.41 for the period, compared to the Thomson Reuters consensus estimate of ($1.14). The company issued revenue guidance of $350 million to $360 million, compared to the consensus revenue estimate of $356.43 million.Teladoc also updated its Q1 guidance to -$0.43 to -$0.45 EPS.
Several equities research analysts recently issued reports on the stock. CIBC restated an outperform rating and set a $45.00 price objective (up from $40.00) on shares of Teladoc in a research report on Tuesday, November 21st. KeyCorp restated a buy rating and set a $41.00 price objective on shares of Teladoc in a research report on Wednesday, January 10th. Jefferies Group began coverage on shares of Teladoc in a research report on Friday, January 26th. They set a buy rating and a $40.00 price target for the company. ValuEngine upgraded shares of Teladoc from a sell rating to a hold rating in a research report on Sunday, December 31st. Finally, Citigroup began coverage on shares of Teladoc in a research report on Thursday, January 4th. They set a buy rating for the company. One equities research analyst has rated the stock with a sell rating, five have given a hold rating and twelve have given a buy rating to the company’s stock. The stock currently has a consensus rating of Buy and an average price target of $40.29.
Teladoc (NYSE TDOC) opened at $40.00 on Thursday. The company has a quick ratio of 5.08, a current ratio of 5.08 and a debt-to-equity ratio of 0.83. Teladoc has a 12 month low of $19.60 and a 12 month high of $41.00. The company has a market cap of $2,302.40, a P/E ratio of -21.22 and a beta of 0.49.
TRADEMARK VIOLATION WARNING: This piece was originally reported by Ticker Report and is owned by of Ticker Report. If you are accessing this piece on another site, it was illegally stolen and republished in violation of US and international trademark and copyright laws. The original version of this piece can be read at https://www.tickerreport.com/banking-finance/3231475/teladoc-tdoc-issues-fy18-earnings-guidance.html.
Teladoc, Inc is a telehealth company. The Company offers telehealth platform, delivering on-demand healthcare anytime, anywhere, through mobile devices, the Internet, video and phone. The Company’s solution connects its Members, with its over 3,000 board certified physicians and behavioral health professionals treating a range of conditions and cases from acute diagnoses, such as upper respiratory infection, urinary tract infection and sinusitis to dermatological conditions, anxiety and smoking cessation.
Receive News & Ratings for Teladoc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teladoc and related companies with MarketBeat.com's FREE daily email newsletter.